Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases

Published:2014-07 Issue:7 Volume:20 Page:1288-1295
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Paul Stephane,Moreau Amelie Carla,Del Tedesco Emilie,Rinaudo Melanie,Phelip Jean-Marc,Genin Christian,Peyrin-Biroulet Laurent,Roblin Xavier

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference25 articles.

1. Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

2. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

3. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

4. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

5. Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

2. Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East;Therapeutic Advances in Gastroenterology;2024-01

3. Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design;Biomedicines;2023-05-16

4. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2023-03-23

5. Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study;Pharmaceutics;2023-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3